Plus, the House Judiciary Committee may put forward new articles of impeachment against President Trump pending a key testimony, and Tesla shares finally hit $420.
Read MorePlus, China is lowing tariffs on more than 850 products from the U.S., Sarepta Therapeutics got a massive investment from Roche, and DraftKings is going public.
Read MoreGoldman Sachs says all three Strong Buy stocks could see double-digit upside next year.
Read MorePlus, Trump was impeached by the House, existing home sales slumped in November, and Micron forecast for its financial recovery in 2020.
Read MoreBuy Target $46.00 or better Sell Target – TradersPro Sell Signal Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company’s lead product candidates include CPI-0610 that is in Phase II clinical […]
Read MorePlus, tech stocks are soaring, questions remain on the U.S.-China phase one trade agreement, and homebuilder confidence surged to its highest level in 20 years this month.
Read MoreThese 2 biotechs could see double digit upside over the next year.
Read MorePlus, China expects the U.S. to delay the next round of tariff increases, House Democrats just announced two articles of impeachment against Trump, and department stores are in trouble.
Read MorePlus, we’re fast approaching the U.S. deadline to impose more tariffs on Chinese goods, House Judiciary Chairman Jerry Nadler said his committee will bring articles of impeachment against Trump this week, and Morgan Stanley says this stock is set to rocket higher.
Read MoreBuy Target – $6.40 or Better Sell Signal – TradersPro Sell Signal Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as […]
Read MorePlus, General Motors and LG Chem are teaming up to build a new battery factory for electric vehicles, and Dollar General delivered an earnings beat.
Read MorePlus, the U.S. and China are reportedly moving closer to a trade agreement despite recent harsh rhetoric, Carl Icahn is urging HP to consider Xerox’s takeover bid, and Expedia shares are rising after a management shakeup.
Read MorePlus, the impeachment inquiry is moving on to the Judiciary Committee, the FAA is tightening its grip on Boeing, and Deere shares are sliding.
Read MoreBuy Target – $2.22 or better Sell Target – TradersPro Sell Signal Veru Inc., an oncology and urology biopharmaceutical company, engages in developing medicines for prostate cancer treatment and prostate cancer supportive care, and urology specialty pharmaceuticals. The company’s commercial products include the FC2 Female/Internal condoms for the prevention of pregnancy and sexually transmitted infections; […]
Read MorePlus, the U.S. and China “reached consensus on properly resolving” key issues in ongoing trade talks, Dick’s Sporting Goods is surging, while Dollar Tree is slipping lower.
Read More